We’ve been working on it for what seems like forever — and day one of Wonderland was a huge success.
World class researchers, heavyweight celebrities like Mike Tyson, and countless entrepreneurs, advocates and investors. The psychedelic medicine industry has officially arrived.
Running from November 8-9, 2021 in Miami, Florida at the Adrienne Arsht Center for the Performing Arts, Wonderland is an impressive collection of global psychedelic medicine leaders, from scientists and researchers, investors and entrepreneurs, therapists and patients, government officials, and media, all championing the growth of the psychedelic medicine industry.
Wonderland day one highlights included:
- Cybin hosting a press conference announcing impressive R&D results of their new drug candidate CYB-003
- Daniel Carcillo, former professional hockey player and CEO of Wesana Health, sat down for a fireside chat with boxing great Mike Tyson for an inspirational talk about the life-changing effects of psychedelics
- Robin Carhart-Harris, Distinguished Professor of Neurology & Psychiatry, Director Psychedelics Division, Neuroscape, UCSF
- Rick Doblin from MAPS in conversation with Microdose CEO Patrick Moher
- Panels included The Pathway to Federal Acceptance, Precision Medicine and Psychedelics, Next-Generation Psychedelics, and many others
The Adrienne Arsht Center was filled with innovative exhibitors, industry-leading sponsors, and entrepreneurs and investors meeting in-person and blazing new paths for the entire industry.
Wonderland day two will continue with:
- Dr. Matthew W. Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins
- Wonderful panels including: Evolution of Ibogaine Treatment, Psilocybin for Smoking Cessation, Investing the Shamanic Way, Patent Wars, Finance and Psychedelics
